Abstract:Desensitization is a physiological feedback mechanism that blocks detrimental effects of persistent stimulation. G protein-coupled receptor kinase 2 (GRK2) was originally identified as the kinase that mediates G protein-coupled receptor (GPCR) desensitization. Subsequent studies revealed that GRK is a family composed of seven isoforms (GRK1-GRK7). Each GRK shows a differential expression pattern. GRK1, GRK4, and GRK7 are expressed in limited tissues. In contrast, GRK2, GRK3, GRK5, and GRK6 are ubiquitously expressed throughout the body. The roles of GRKs in GPCR desensitization are well established. When GPCRs are activated by their agonists, GRKs phosphorylate serine/threonine residues in the intracellular loops and the carboxyl-termini of GPCRs. Phosphorylation promotes translocation of β-arrestins to the receptors and inhibits further G protein activation by interrupting receptor-G protein coupling. The binding of β-arrestins to the receptors also helps to promote receptor internalization by clathrin-coated pits. Thus, the GRK-catalyzed phosphorylation and subsequent binding of β-arrestin to GPCRs are believed to be the common mechanism of GPCR desensitization and internalization. Recent studies have revealed that GRKs are also involved in the β-arrestin-mediated signaling pathway. The GRK-mediated phosphorylation of the receptors plays opposite roles in conventional G protein- and β-arrestin-mediated signaling. The GRK-catalyzed phosphorylation of the receptors results in decreased G protein-mediated signaling, but it is necessary for β-arrestin-mediated signaling. Agonists that selectively activate GRK/β-arrestin-dependent signaling without affecting G protein signaling are known as β-arrestin-biased agonists. Biased agonists are expected to have potential therapeutic benefits for various diseases due to their selective activation of favorable physiological responses or avoidance of the side effects of drugs. Furthermore, GRKs are recognized as signaling mediators that are independent of either G protein- or β-arrestin-mediated pathways. GRKs can phosphorylate non-GPCR substrates, and this is found to be involved in various physiological responses, such as cell motility, development, and inflammation. In addition to these effects, our group revealed that GRK6 expressed in macrophages mediates the removal of apoptotic cells (engulfment) in a kinase activity-dependent manner. These studies revealed that GRKs block excess stimulus and also induce cellular responses. Here, we summarized the involvement of GRKs in β-arrestin-mediated and G protein-independent signaling pathways.

Molecular cloning and expression of GRK6. A new member of the G protein-coupled receptor kinase family.

Expression, purification, and characterization of the G protein-coupled receptor kinase GRK6.

Protein kinases that phosphorylate activated G protein‐coupled receptors

GRK2/3/5/6 knockout: The impact of individual GRKs on arrestin-binding and GPCR regulation

Palmitoylation of G protein-coupled receptor kinase, GRK6. Lipid modification diversity in the GRK family.

Altered Activity of Palmitoylation-deficient and Isoprenylated Forms of the G Protein-coupled Receptor Kinase GRK6

GPCR kinase knockout cells reveal the impact of individual GRKs on arrestin binding and GPCR regulation

The G protein-coupled receptor kinase (GRK) interactome: Role of GRKs in GPCR regulation and signaling

G protein-coupled receptor kinases: More than just kinases and not only for GPCRs

Pathophysiological roles of G-protein-coupled receptor kinases

The GPCR, class C, group 6, subtype A (GPRC6A) receptor: from cloning to physiological function

Multiple functions of G protein-coupled receptor kinases

GRK6 phosphorylates IκBα at Ser32/Ser36 and enhances TNF-α-induced inflammation

[Cloning and Tissue Expressive Pattern Analysis of the Human Ribosomal S6 Kinase-Rps6ka5 Cdna].

Regulation of EGF-induced ERK/MAPK Activation and EGFR Internalization by G Protein-Coupled Receptor Kinase 2.

Cdna Cloning, Expression Studies and Chromosome Mapping of Human Type I Serine/threonine Kinase Receptor ALK7 (ACVR1C)

A Non-Canonical Function of Gβ As a Subunit of E3 Ligase in Targeting GRK2 Ubiquitylation.

Isolation and characterisation of the human lung NK-1 receptor cDNA

Molecular Cloning, Genomic Organization, and Mapping of PRKAG2, a Heart Abundant Γ2 Subunit of 5′-Amp-activated Protein Kinase, to Human Chromosome 7Q36

Differential Regulation of GPCRs—Are GRK Expression Levels the Key?

Role of GRK6 in the Regulation of Platelet Activation through Selective G Protein-Coupled Receptor (GPCR) Desensitization